A Randomized controlled trial of combined Behavioral couples therapy with motivational interviewing to reduce intimate partner violence and alcohol use in urban primary health center, South India
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2022 - Ongoing
Project Lead
National Institute of Mental Health
Authors
Collaborative research with Mental Health and Neuroscience division SJRI and UCSF – Dr. Srinivas, Mrs. Nisha C.K.
Project Status
ongoing
Project Type
Faculty